Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-10 Purchase | 2022-11-14 08:40 am | Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner | 4,000,000 | $5 | $20,000,000 | 102,849,443 (Direct) | View |
| 2022-04-22 Purchase | 2022-04-26 06:48 am | Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner | 40,285 | $3.8464 | $154,954 | 98,849,443 (Direct) | View |
| 2021-06-02 Sale | 2021-06-03 5:40 pm | Protalix BioTherapeutics Inc. | PLX | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 918,717 | $2.2737 | $2,088,857 | 3,637,314 (Direct) | View |
| 2020-01-31 Sale | 2020-02-04 6:41 pm | Intec Pharma Ltd. | NTEC | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 915,951 | $0.3075 | $281,659 | 4,234,897 (Direct) | View |
| 2019-06-17 Purchase | 2019-06-19 6:24 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 18,204 | $8.3158 | $151,381 | 22,860,013 (Indirect) | View |
| 2019-06-12 Purchase | 2019-06-14 6:10 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 22,011 | $8.0551 | $177,301 | 22,841,809 (Indirect) | View |
| 2019-06-07 Purchase | 2019-06-11 6:19 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 21,338 | $8.3067 | $177,247 | 22,819,798 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:29 pm | Myovant Sciences Ltd. | MYOV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,599 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 6:25 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 21,122 | $7.8567 | $165,950 | 22,798,460 (Indirect) | View |
| 2019-05-30 Purchase | 2019-06-03 6:33 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 17,746 | $7.8297 | $138,946 | 22,777,338 (Indirect) | View |
| 2019-05-24 Purchase | 2019-05-29 6:28 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 14,485 | $7.6259 | $110,461 | 22,759,592 (Indirect) | View |
| 2019-05-22 Purchase | 2019-05-28 4:41 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 9,835 | $7.9115 | $77,810 | 22,745,107 (Indirect) | View |
| 2019-05-21 Purchase | 2019-05-23 5:04 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 9,995 | $8.5151 | $85,108 | 22,735,272 (Indirect) | View |
| 2019-05-20 Purchase | 2019-05-22 4:21 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 10,000 | $8.0525 | $80,525 | 22,725,277 (Indirect) | View |
| 2019-05-16 Purchase | 2019-05-20 4:21 pm | Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 11,608 | $7.0951 | $82,359 | 22,715,277 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2021-10-01 5:02 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner | 0 | $0 | 98,809,158 (Direct) | View |
Ownership | 2021-02-16 12:07 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 0 | $0 | 7,372,932 (Direct) | View |